Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Prospective evaluation of analgesic use and risk of renal cell cancer.

Cho E, Curhan G, Hankinson SE, Kantoff P, Atkins MB, Stampfer M, Choueiri TK.

Arch Intern Med. 2011 Sep 12;171(16):1487-93. doi: 10.1001/archinternmed.2011.356.

2.

Kidney cancer: long-term use of nonaspirin NSAIDs increases RCC risk.

Fenner A.

Nat Rev Urol. 2011 Oct 4;8(11):590. doi: 10.1038/nrurol.2011.148. No abstract available.

PMID:
21971317
3.

A large cohort study of nonsteroidal anti-inflammatory drugs and renal cell carcinoma incidence in the National Institutes of Health-AARP Diet and Health Study.

Liu W, Park Y, Purdue MP, Giovannucci E, Cho E.

Cancer Causes Control. 2013 Oct;24(10):1865-73. doi: 10.1007/s10552-013-0263-4. Epub 2013 Jul 19.

4.

Analgesic use and risk of renal cell carcinoma: A case-control, cohort and meta-analytic assessment.

Karami S, Daughtery SE, Schwartz K, Davis FG, Ruterbusch JJ, Wacholder S, Graubard BI, Berndt SI, Hofmann JN, Purdue MP, Moore LE, Colt JS.

Int J Cancer. 2016 Aug 1;139(3):584-92. doi: 10.1002/ijc.30108. Epub 2016 Apr 9.

5.

Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and risk of breast cancer among premenopausal women in the Nurses' Health Study II.

Eliassen AH, Chen WY, Spiegelman D, Willett WC, Hunter DJ, Hankinson SE.

Arch Intern Med. 2009 Jan 26;169(2):115-21; discussion 121. doi: 10.1001/archinternmed.2008.537.

6.

Regular use of analgesics is a risk factor for renal cell carcinoma.

Gago-Dominguez M, Yuan JM, Castelao JE, Ross RK, Yu MC.

Br J Cancer. 1999 Oct;81(3):542-8.

7.

Aspirin and risk of renal cell cancer in Italy.

Tavani A, Scotti L, Bosetti C, Dal Maso L, Montella M, Ramazzotti V, Negri E, Franceschi S, La Vecchia C.

Eur J Cancer Prev. 2010 Jul;19(4):272-4. doi: 10.1097/CEJ.0b013e3283394750.

PMID:
20351553
8.

Lifetime nonnarcotic analgesic use and decline in renal function in women.

Curhan GC, Knight EL, Rosner B, Hankinson SE, Stampfer MJ.

Arch Intern Med. 2004 Jul 26;164(14):1519-24.

PMID:
15277282
9.

Duration of Analgesic Use and Risk of Hearing Loss in Women.

Lin BM, Curhan SG, Wang M, Eavey R, Stankovic KM, Curhan GC.

Am J Epidemiol. 2017 Jan 1;185(1):40-47. doi: 10.1093/aje/kww154. Epub 2016 Dec 14.

10.

Use of nonsteroidal antiinflammatory agents and incidence of ovarian cancer in 2 large prospective cohorts.

Pinheiro SP, Tworoger SS, Cramer DW, Rosner BA, Hankinson SE.

Am J Epidemiol. 2009 Jun 1;169(11):1378-87. doi: 10.1093/aje/kwp062. Epub 2009 Apr 2.

11.

Nonsteroidal anti-inflammatory drugs and risk of prostate cancer in the Baltimore Longitudinal Study of Aging.

Platz EA, Rohrmann S, Pearson JD, Corrada MM, Watson DJ, De Marzo AM, Landis PK, Metter EJ, Carter HB.

Cancer Epidemiol Biomarkers Prev. 2005 Feb;14(2):390-6.

12.

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.

JAMA. 2005 Aug 24;294(8):914-23.

13.

Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease.

Chen H, Zhang SM, Hernán MA, Schwarzschild MA, Willett WC, Colditz GA, Speizer FE, Ascherio A.

Arch Neurol. 2003 Aug;60(8):1059-64.

PMID:
12925360
14.

Analgesic use and sex steroid hormone concentrations in postmenopausal women.

Gates MA, Tworoger SS, Eliassen AH, Missmer SA, Hankinson SE.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1033-41. doi: 10.1158/1055-9965.EPI-09-0975. Epub 2010 Mar 23.

15.

Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts.

Liu W, Choueiri TK, Cho E.

Cancer. 2012 Feb 1;118(3):797-803. doi: 10.1002/cncr.26338. Epub 2011 Jul 12.

16.

Nonsteroidal antiinflammatory drug use and risk of bladder cancer in the health professionals follow-up study.

Genkinger JM, De Vivo I, Stampfer MJ, Giovannucci E, Michaud DS.

Int J Cancer. 2007 May 15;120(10):2221-5.

17.

Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status.

Marshall SF, Bernstein L, Anton-Culver H, Deapen D, Horn-Ross PL, Mohrenweiser H, Peel D, Pinder R, Purdie DM, Reynolds P, Stram D, West D, Wright WE, Ziogas A, Ross RK.

J Natl Cancer Inst. 2005 Jun 1;97(11):805-12.

PMID:
15928301
18.

Nonnarcotic analgesic use and the risk of hypertension in US women.

Dedier J, Stampfer MJ, Hankinson SE, Willett WC, Speizer FE, Curhan GC.

Hypertension. 2002 Nov;40(5):604-8; discussion 601-3.

19.

Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.

Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ; Australian Ovarian Cancer Study Group, Australian Cancer Study (Ovarian Cancer), Risch HA, Rossing MA, Doherty JA, Goodman MT, Lurie G, Kjær SK, Hogdall E, Jensen A, Cramer DW, Terry KL, Vitonis A, Bandera EV, Olson S, King MG, Chandran U, Anton-Culver H, Ziogas A, Menon U, Gayther SA, Ramus SJ, Gentry-Maharaj A, Wu AH, Pearce CL, Pike MC, Berchuck A, Schildkraut JM, Wentzensen N; Ovarian Cancer Association Consortium.

J Natl Cancer Inst. 2014 Feb;106(2):djt431. doi: 10.1093/jnci/djt431.

20.

Frequency of analgesic use and risk of hypertension in younger women.

Curhan GC, Willett WC, Rosner B, Stampfer MJ.

Arch Intern Med. 2002 Oct 28;162(19):2204-8.

PMID:
12390063

Supplemental Content

Support Center